PL

Pankaj Loknath Singh

Active Director Director DIN 07562585
DIN 07562585 First appointment Jul 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2016
Shareholding value •••• Premium profile

About Pankaj Loknath Singh

Data last updated:

Pankaj Loknath Singh is a Director at Macindia Life Sciences Private Limited (since 2016). The company operates in Pharma. Macindia Life Sciences Private Limited reported revenue of ₹1.62 Cr (FY 2025).

DIN 07562585
Primary Designation Director
Industry Pharma
First Appointment 22 Jul 2016
Oldest Company Age 10 yrs
Largest company Macindia Life Sciences Private Limited · ₹1.62 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Jul 20162016₹1.62 Cr (FY 2025)Active

Board colleagues of Pankaj Loknath Singh

Directorship timeline

Open interactive timeline →
Macindia Life Sciences Private Limited
Premium access

Shareholding and investment profile for Pankaj Loknath Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pankaj Loknath Singh

Pankaj Loknath Singh currently holds 1 directorship: Macindia Life Sciences Private Limited (Director, since 22 Jul 2016, revenue ₹1.62 Cr (FY 2025)).

Pankaj Loknath Singh was first appointed on 22 Jul 2016 as Director at Macindia Life Sciences Private Limited.

The current boards of Pankaj Loknath Singh's companies include Chandrakant Vithal Sawant (Macindia Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available